Both in Biotechnology
Elutia vs INmune Bio
Over the past year ELUT returned −6.3% and INMB returned −15.9%; their daily moves had a correlation of 0.06.
ELUT −6.3% INMB −15.9%Growth of $1, one year, split-adjusted
| Metric | ELUT | INMB |
|---|---|---|
| Price | $0.8399 | $1.53 |
| Market cap | $37.2M | $42.5M |
| Today | +4.36% | +0.66% |
| 1 month | +6.5% | −21.9% |
| 6 months | −16.0% | +15.0% |
| Year to date | +21.3% | −1.9% |
| 1 year | −6.7% | −16.8% |
| Revenue growth (YoY) | −11.6% | — |
| Gross margin | 59.6% | — |
| Net margin | −315.0% | — |
| P/E (TTM) | 0.7× | — |
| Price / sales | 3.1× | — |
| Net cash | $19.9M | $18.4M |
| Dividend yield | — | — |
| Volatility (60d) | 61.1% | 63.6% |
| Short % of float | 0.0% | 11.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).